Biom Pharma is dedicated to achieving one of the most ambitious goals of 21st century medicine: increasing human longevity with high quality of life. This objective is at the heart of everything we do, from early research and development to product development. With this goal in mind we are focusing on developing true-to-label nutritional supplements to novel microbiome services to developing therapeutic modalities against hard-to-treat diseases. To bring about this transformation, we are developing innovative designer drug products that harness a patient’s own microbiome to target various disease and pathological conditions. Our innovative team of scientists, business leaders and engineers are focused on developing clinical-based microbiome technologies and services to address various metabolic and immune diseases. The company has developed several cutting-edge technologies for healthcare and consumer care market applications.
There is no investment information
No recent news or press coverage available for Biom Pharmaceutical Corporation.
We care about your data, and we'd love to use cookies make your experience better.
